ICi 204,636: a new atypical antipsychotic drug
Hirsch, S.R.; Link, C.G.; Goldstein, J.M.; Arvanitis, L.A.
British Journal of Psychiatry. Suppl 29: 45-56
1996
ISSN/ISBN: 0960-5371 PMID: 8733823 Document Number: 466422
Document emailed within 1 workday
Related Documents
Baker, R.A.; Pikalov, A.; Tran, Q-Van.; Kremenets, T.; Arani, R.B.; Doraiswamy, P.Murali. 2009: Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis Psychopharmacology Bulletin 42(1): 11-31O'Reilly, D.J.; Goeree, R.A.; Tarride, J-Eric.; James, C.; Parfrey, P.S. 2009: The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06 Canadian Journal of Clinical Pharmacology 16(2): E346-E359
Lecrubier, Y. 2000: Is amisulpride an 'atypical' atypical antipsychotic agent? International Clinical Psychopharmacology 15(Suppl 4): S21-S26
Godlewska, B.R.; Olajossy-Hilkesberger, L.; Marmurowska-Michałowska, H.; Olajossy, M.; Landowski, J. 2006: Atypical antipsychotic-induced weight gain Psychiatria Polska 40(5): 995-1007
Dumortier, G.; Cabaret, W.; Stamatiadis, L.; Saba, G.; Benadhira, R.; Rocamora, J.-F.; Aubriot-Delmas, B.; Glikman, J.; Januel, D. 2002: Hepatic tolerance of atypical antipsychotic drugs L'Encephale 28(6 Part 1): 542-551
Jones, B.; Basson, B.R.; Walker, D.J.; Crawford, A.M.; Kinon, B.J. 2001: Weight change and atypical antipsychotic treatment in patients with schizophrenia Journal of Clinical Psychiatry 62(Suppl): 41-44
Weiden, P.; Aquila, R.; Standard, J. 1996: Atypical antipsychotic drugs and long-term outcome in schizophrenia Journal of Clinical Psychiatry 57(Suppl): 53-60
Omori, T. 2001: Efficacy of atypical antipsychotic agents for maintenance therapy of schizophrenia Seishin Shinkeigaku Zasshi 103(6): 470-475
Alphs, L.D.; Lee, H.S. 1991: Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study Journal of Clinical Psychiatry 52(8): 346-348
Ivanets, N.N.; Kinkul'kina, M.A.; Avdeeva, T.I. 2011: The experience of using the atypical antipsychotic sertindole in psychiatric inpatient clinics in Russia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(6): 37-41
Gram, L.F. 2000: Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine Ugeskrift for Laeger 162(13): 1914-1915
Franza, F. 2016: Risk and efficacy in cognitive functions in Bipolar Disorder Ii with atypical antipsychotic augmentation Psychiatria Danubina 28(Suppl-1): 13-17
Roth, B.L.; Ciaranello, R.D.; Meltzer, H.Y. 1992: Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors Journal of Pharmacology and Experimental Therapeutics 260(3): 1361-1365
Vohora, D. 2007: Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia Current Opinion in Investigational Drugs 8(7): 531-538
Ohno, Y.; Ishida-Tokuda, K.; Ishibashi, T.; Sakamoto, H.; Tagashira, R.; Horisawa, T.; Yabuuti, K.; Matsumoto, K.; Kawabe, A.; Nakamura, M. 1997: Potential role of 5-HT2 and D2 receptor interaction in the atypical antipsychotic action of the novel succimide derivative, perospirone Polish Journal of Pharmacology 49(4): 213-219
Wongniyom, K.; Rangseekajee, P. 2012: Remission rate of atypical antipsychotic treatment of bipolar depression: experience at Srinagarind Hospital, northeast Thailand Journal of the Medical Association of Thailand 95(1): 105-110
Moerkens, R.M.; Dhondt, A.D.F. 2003: Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine Nederlands Tijdschrift Voor Geneeskunde 147(14): 679; Author Reply 679
Srisurapanont, M.; Maneeton, N. 1999: Comparison of the efficacy and acceptability of atypical antipsychotic drugs: a meta-analysis of randomized, placebo-controlled trials Journal of the Medical Association of Thailand 82(4): 341-346
Shoshina, I.I.; Shelepin, I.E.; Semenova, N.B. 2014: The frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia with the therapy of atypical and typical antipsychotic drugs Fiziologiia Cheloveka 40(1): 43-48
Nyberg, S.; Nakashima, Y.; Nordström, A.L.; Halldin, C.; Farde, L. 1996: Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response British Journal of Psychiatry. Supplement 1996(29): 40-44